Literature DB >> 30361931

Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level.

Muhammed A Saad1, Ayman E El-Sahar1, Rabab H Sayed2, Eman M Elbaz3, Hebatullah S Helmy3, Mahmoud A Senousy3.   

Abstract

Reduced estradiol levels are associated with depression in women during the transition to and after menopause. A considerable number of studies focusing on the theme of treating depression through the activation of erythropoietin (EPO)-induced signaling pathways have been published. Venlafaxine is an approved antidepressant drug that inhibits both serotonin and norepinephrine transporters. The aim of the present study was to investigate the effects of venlafaxine on the depressive-like behaviors and serum estradiol levels in female rats following ovariectomy (OVX) and the possible roles of EPO-induced signaling pathways. Venlafaxine (10 mg/kg/day) was orally administered to OVX rats over a period of 4 weeks using two different treatment regimens: either starting 24 h or 2 weeks after OVX. Venlafaxine showed a superior efficacy in inducing antidepressant-like effects after an acute treatment (24 h post-OVX) than after the delayed treatment (2 weeks post-OVX) and was characterized by a decreased immobility time in the forced swimming test. In parallel, venlafaxine induced EPO and EPO receptor mRNA expression and increased levels of phospho-Janus kinase 2 (p-JAK2), phospho-signal transducer and activator of transcription 5, and phospho-extracellular signal-regulated kinase 1/2 in the hippocampus of OVX rats. Meanwhile, rats exhibited a marked reduction in the hippocampal Bax/Bcl2 ratio, caspase-3 activity, and tumor necrosis factor alpha levels after venlafaxine treatment. Venlafaxine also increased the hippocampal brain-derived neurotrophic factor and serum estradiol levels. Based on these findings, venlafaxine exerts a neuroprotective effect on OVX rats that is at least partially attributed to the activation of EPO/EPOR/JAK2 signaling pathways, anti-apoptotic activities, anti-inflammatory activities, and neurotrophic activities, as well as an increase in serum estradiol level. Graphical Abstract ᅟ.

Entities:  

Keywords:  Apoptosis; EPO/EPOR; JAK2; ovariectomy; postmenopausal depression; venlafaxine

Mesh:

Substances:

Year:  2019        PMID: 30361931      PMCID: PMC6554373          DOI: 10.1007/s13311-018-00680-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  58 in total

1.  Chronic fluoxetine suppresses circulating estrogen and the enhanced spatial learning of estrogen-treated ovariectomized rats.

Authors:  George T Taylor; Susan Farr; Klaus Klinga; Juergen Weiss
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

2.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

3.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  Postmenopausal hormone therapy: risks and benefits.

Authors:  Serge Rozenberg; Jean Vandromme; Caroline Antoine
Journal:  Nat Rev Endocrinol       Date:  2013-02-19       Impact factor: 43.330

5.  Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.

Authors:  Varuni Asanka de Silva; Raveen Hanwella
Journal:  Int Clin Psychopharmacol       Date:  2012-01       Impact factor: 1.659

6.  The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.

Authors:  Cecilie Hurup Hansen; Lizette Weber Larsen; Amalie Møller Sørensen; Bent Halling-Sørensen; Bjarne Styrishave
Journal:  Toxicol In Vitro       Date:  2017-02-05       Impact factor: 3.500

7.  Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.

Authors:  Yiming Wang; Zhengjun Xiao; Xingde Liu; Michael Berk
Journal:  Hum Psychopharmacol       Date:  2011-02-09       Impact factor: 1.672

8.  BAX is required for neuronal death after trophic factor deprivation and during development.

Authors:  T L Deckwerth; J L Elliott; C M Knudson; E M Johnson; W D Snider; S J Korsmeyer
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

9.  The role of monoamine metabolism in oxidative glutamate toxicity.

Authors:  P Maher; J B Davis
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase.

Authors:  Ingo Flamme; Peter Ellinghaus; Diana Urrego; Thilo Krüger
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more
  8 in total

Review 1.  Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.

Authors:  Claire Rampon; Bruno P Guiard; Basile Coutens; Antoine Yrondi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-10       Impact factor: 4.415

2.  Inflammatory Modulation of miR-155 Inhibits Doxorubicin-Induced Testicular Dysfunction via SIRT1/FOXO1 Pathway: Insight into the Role of Acacetin and Bacillus cereus Protease.

Authors:  Hend Mohamed Anwar; Sherin Ramadan Hamad; Gad Elsayed Mohamed Salem; Rania Hassan Mohamed Soliman; Eman Maher Elbaz
Journal:  Appl Biochem Biotechnol       Date:  2022-06-18       Impact factor: 3.094

3.  Food Allergy-Induced Autism-Like Behavior is Associated with Gut Microbiota and Brain mTOR Signaling.

Authors:  Li-Hua Cao; Hong-Juan He; Yuan-Yuan Zhao; Zhen-Zhen Wang; Xing-Yuan Jia; Kamal Srivastava; Ming-San Miao; Xiu-Min Li
Journal:  J Asthma Allergy       Date:  2022-05-16

4.  The Effect of Chronic Mild Stress and Venlafaxine on the Expression and Methylation Levels of Genes Involved in the Tryptophan Catabolites Pathway in the Blood and Brain Structures of Rats.

Authors:  Paulina Wigner; Ewelina Synowiec; Paweł Jóźwiak; Piotr Czarny; Michał Bijak; Katarzyna Białek; Janusz Szemraj; Piotr Gruca; Mariusz Papp; Tomasz Śliwiński
Journal:  J Mol Neurosci       Date:  2020-05-13       Impact factor: 3.444

5.  PI3K-AKT Signaling Activation and Icariin: The Potential Effects on the Perimenopausal Depression-Like Rat Model.

Authors:  Li-Hua Cao; Jing-Yi Qiao; Hui-Yuan Huang; Xiao-Yan Fang; Rui Zhang; Ming-San Miao; Xiu-Min Li
Journal:  Molecules       Date:  2019-10-15       Impact factor: 4.411

6.  Effectiveness and mechanisms of adipose-derived stem cell therapy in animal models of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Keya Li; Xinyue Li; Guiying Shi; Xuepei Lei; Yiying Huang; Lin Bai; Chuan Qin
Journal:  Transl Neurodegener       Date:  2021-04-29       Impact factor: 8.014

Review 7.  Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression.

Authors:  John Q Wang; Justin D Derges; Alaya Bodepudi; Nikhila Pokala; Li-Min Mao
Journal:  J Integr Neurosci       Date:  2022-01-28       Impact factor: 2.117

8.  MicroRNA-99a is a Potential Target for Regulating Hypothalamic Synaptic Plasticity in the Peri/Postmenopausal Depression Model.

Authors:  Jin Yang; Ling Zhang; Lu-Lu Cao; Jun Qi; Ping Li; Xi-Peng Wang; Xiu-Lan Sun
Journal:  Cells       Date:  2019-09-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.